Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer

Journal of the American College of Surgeons

Volumn 193, Issue 6, 2001, Pages 626-632

  Gillette Cloven, Noelle ^a   Burger, Robert A ^a,c   Monk, Bradley J ^a   McMeekin, D Scott ^a   Vasilev, Steven ^b   DiSaia, Philip J ^a   Kohler, Matthew F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; PLATINUM DERIVATIVE;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HEART DISEASE; HERNIA; HUMAN; ILEUS; INTESTINE FISTULA; INTESTINE OBSTRUCTION; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MORBIDITY; OPERATION DURATION; OVARY CARCINOMA; PNEUMONIA; PRIORITY JOURNAL; REOPERATION; SEPSIS; SURGICAL MORTALITY; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; INTESTINES; INTRAOPERATIVE COMPLICATIONS; LIFE TABLES; MIDDLE AGED; OVARIAN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0035201884     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(01)01090-0     Document Type: Article

References (27)

1. Epithelial ovarian cancer
2. The role of cytoreductive surgical treatment in the management of advanced ovarian cancer
3. Does cytoreduction surgery improve survival in biologically aggressive ovarian carcinoma?
4. Tumor reduction surgery and long term survival in advanced ovarian cancer: A DACOVA study
5. Primary cytoreductive surgery for epithelial ovarian cancer
6. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study
7. Cis-platin based combination chemotherapy for advanced ovarian cancer
8. Stage III epithelial ovarian cancer: The role of maximal surgical resection
9. Complete cytoreduction: Is epithelial ovarian cancer confined to the pelvis biologically different from bulking abdominal disease?
10. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study
11. Intestinal operations in patients with ovarian cancer
12. Significance of cytoreductive surgery including bowel resection for patients with advanced ovarian cancer
13. The potential for optimal (< 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective study
14. Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidity
15. Stage IV ovarian cancer: Impact of surgical cytoreduction
16. Primary surgical therapy of ovarian cancer: How much and when
17. Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinoma
18. The impact of subspecialty training on the management of advanced ovarian cancer
19. The role of bowel surgery in the primary treatment of epithelial ovarian cancer
20. The role of bowel resection in the primary surgical cytoreduction of carcinoma of the ovary
21. Primary cytoreductive surgery with rectosigmoid resection for patients with advanced epithelial ovarian carcinoma
22. Second look laparotomy after modified posterior exenteration: Patterns of persistence and recurrence in patients with stage III and IV ovarian cancer
23. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer
24. The role of partial sigmoid colectomy for cytoreduction epithelial ovarian carcinoma
25. Modified posterior exenteration for ovarian cancer
26. A retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian cancer
27. Gastrointestinal surgery in patients with ovarian cancer